PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
Activity Narrative:
ACTIVITY HAS BEEN MODIFIED IN THE FOLLOWING WAYS: TO STRENGTHEN THE MINISTRY OF
HEALTH LABORATORY SERVICE UNIT, THE NATIONAL QUALITY ASSURANCE LABORATORY
PROGRAM AND ITS COORDINATION ROLES
This activity is linked with Centers for Disease Control and Prevention - Technical Assistance (CDC-TA
#3706.08), Tropical Diseases Research Center (TDRC #3702.08), University Teaching Hospital (UTH
#9798), Ministry of Health Laboratory information System (MOH-LIS), Associated Public Health laboratories
(APHL ), EGPAF-CIDRZ (#16956), adult and pediatric care and treatment and all activities within the
Laboratory section.
The Chest Diseases Laboratory (CDL) is Zambia's National Reference Laboratory for Tuberculosis (TB). It
is administered under the Ministry of Health (MOH) and has a strong link with the MOH Laboratory Services
Unit. This facility is responsible for quality assurance of TB microscopy, culture, and drug susceptibility
testing in the TB laboratory network
In FY 2006, the MOH developed a national operational strategic plan to include four laboratory tests as
components of its quality assurance program. HIV rapid testing, CD4, chemistry, and hematology were
included. The TB external quality assurance (EQA) system has already been established and is supported
by United States Government (USG) funding provided directly to CDL, the University Teaching Hospital
(UTH) and the Tropical Disease Research Centre (TDRC) for activities in all Provincial levels. District level
EQA is supported through direct co-operative agreements with the Eastern, Lusaka, Southern, and Western
Provincial Health Offices. The Tuberculosis Control Assistance Program (TBCAP) provides support for
EQA at the district level in the northern half of Zambia. Implementation of a quality assurance (QA)
program for rapid HIV testing has begun. In this context, there is a clear need to develop and/or strengthen
the national QA program for those laboratories performing the testing. In FY 2009, the USG will support the
MOH laboratory services unit through the CDL Cooperative Agreement mechanism to strengthen and
develop an integrated QA lab program.
While CDL collaborates with the Global Funds, TBCAP, and ZAMBART, PEPFAR funds received from FY
2007-FY 2008 were used to support the placement of five additional laboratory staff at CDL and
procurement of equipment and support for supervisory visits to the provinces. As a result of this multi-
lateral support, CDL is well equipped to provide technical assistance to two reference laboratories (North
Region TB Reference Laboratory at TDRC, and the UTH TB laboratory as well as supporting provincial,
district and health centers in all provinces.
In FY 2009, CDL will conduct the following activities with $180,000 available funds; 1) continue to provide
support for the extra staff hired at CDL; 2) continue to support CDL staff to supervise the TDRC, UTH TB
labs, and district laboratories in conjunction with other partners; 3) procure, maintain, and provide support
for the maintenance and servicing of laboratory equipment; 4) procure and/or generate, store, and
distribute external quality control materials or panels to be used for the MOH external quality assurance
scheme (EQAS). The panels for TB smear diagnosis will be generated at CDL, panels for HIV rapid testing
will be developed at UTH Virology laboratory.
4) hire a laboratory QA program manager/coordinator to co-ordinate, develop work plans and execute
program activities in collaboration with CDC and its partners; 5) develop, finalize and disseminate the MOH
QA plans and guidelines; 6) support for staff training.
In FY 2009 with activity funding ($120,000) MOH will ensure: 1) CD4 panels will be procured from an
established organization; 2) oversee the development and execution of the EQAS program within the
country for HIV rapid testing, TB, CD4, chemistry, and hematology in collaboration with CDL, UTH Virology,
and CDC; 3) collect, enter, analyze, and disseminate data generated from the QA program; 4) co-ordinate
and support national QA workshops, laboratory -related meetings and/or trainings and equipment. 5)
develop a national public health laboratory (NPHL). In collaboration with CDC and other donors, this activity
will support a work plan design and its development in order to establish a NPHL. This would include
developing a goal, mission, and functions of a NPHL, designing laboratories and building according to its
function; developing a plan for human resources and an operational strategy plus procuring supplies
essential for the early stage of this process. The development of a NPHL would establish a sustainable
national QA laboratory program and ensure quality laboratory testing and results for Zambia.
New/Continuing Activity: Continuing Activity
Continuing Activity: 15510
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
15510 3703.08 HHS/Centers for Chest Diseases 7166 3010.08 CDL - $100,100
Disease Control & Laboratory U62/CCU02319
Prevention 0
8991 3703.07 HHS/Centers for Chest Diseases 4999 3010.07 CDL - $200,000
3703 3703.06 HHS/Centers for Chest Diseases 3010 3010.06 CDL $200,000
Disease Control & Laboratory
Prevention
Emphasis Areas
Health-related Wraparound Programs
* TB
Workplace Programs
Human Capacity Development
Estimated amount of funding that is planned for Human Capacity Development $100,000
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Table 3.3.16:
